Effect of Dapagliflozin on Hematocrit in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From DECLARE-TIMI 58.
Ahmed A KolkailahStephen D WiviottItamar RazSabina A MurphyLawrence A LeiterDeepak L BhattLawrence A LeiterJohn P H WildingIngrid Gause-NilssonMarc S SabatineDarren K McGuirePublished in: Diabetes care (2022)
Keyphrases